Literature DB >> 17989715

T(3;7)(q27;q32) fuses BCL6 to a non-coding region at FRA7H near miR-29.

B Schneider, S Nagel, M Kaufmann, S Winkelmann, J Bode, H G Drexler, R A F MacLeod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17989715     DOI： 10.1038/sj.leu.2405025

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

Review 1.  A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements.

Authors:  Marie Jarosova; Eva Kriegova; Petra Schneiderova; Regina Fillerova; Vit Prochazka; Michaela Mikesova; Patrik Flodr; Karel Indrak; Tomas Papajik
Journal:  Pathol Oncol Res       Date:  2015-08-30       Impact factor: 3.201

2.  Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Authors:  Andrew L Feldman; Ahmet Dogan; David I Smith; Mark E Law; Stephen M Ansell; Sarah H Johnson; Julie C Porcher; Nazan Ozsan; Eric D Wieben; Bruce W Eckloff; George Vasmatzis
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

Review 3.  Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).

Authors:  Krystyna Mazan-Mamczarz; Ronald B Gartenhaus
Journal:  Leuk Res       Date:  2013-09-07       Impact factor: 3.156

4.  miRNA-convergent gene fusions.

Authors:  Carlos Rovira
Journal:  Mol Cell Oncol       Date:  2017-12-11

Review 5.  Fragility Extraordinaire: Unsolved Mysteries of Chromosome Fragile Sites.

Authors:  Wenyi Feng; Arijita Chakraborty
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

6.  Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.

Authors:  Sally E Trabucco; Rachel M Gerstein; Andrew M Evens; James E Bradner; Leonard D Shultz; Dale L Greiner; Hong Zhang
Journal:  Clin Cancer Res       Date:  2014-07-09       Impact factor: 12.531

7.  hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a.

Authors:  Bing He; Yu-Feng Xiao; Bo Tang; Yu-Yun Wu; Chang-Jiang Hu; Rui Xie; Xin Yang; Song-Tao Yu; Hui Dong; Xiao-Yan Zhao; Ji-Liang Li; Shi-Ming Yang
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

8.  Non-coding RNAs in cancers with chromosomal rearrangements: the signatures, causes, functions and implications.

Authors:  Cai Han; Lin-Yu Sun; Wen-Tao Wang; Yu-Meng Sun; Yue-Qin Chen
Journal:  J Mol Cell Biol       Date:  2019-10-25       Impact factor: 6.216

9.  DNA synthesis by Pol η promotes fragile site stability by preventing under-replicated DNA in mitosis.

Authors:  Valérie Bergoglio; Anne-Sophie Boyer; Erin Walsh; Valeria Naim; Gaëlle Legube; Marietta Y W T Lee; Laurie Rey; Filippo Rosselli; Christophe Cazaux; Kristin A Eckert; Jean-Sébastien Hoffmann
Journal:  J Cell Biol       Date:  2013-04-22       Impact factor: 10.539

10.  Frequent miRNA-convergent fusion gene events in breast cancer.

Authors:  Helena Persson; Rolf Søkilde; Jari Häkkinen; Anna Chiara Pirona; Johan Vallon-Christersson; Anders Kvist; Fredrik Mertens; Åke Borg; Felix Mitelman; Mattias Höglund; Carlos Rovira
Journal:  Nat Commun       Date:  2017-10-05       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.